First half 2008: Strong financial results
. - Sales € 5.7 billion, +2 % at actual rates, +9 % in constant currency - EBIT € 781 million, +0 % at actual rates, +…
. - Sales € 5.7 billion, +2 % at actual rates, +9 % in constant currency - EBIT € 781 million, +0 % at actual rates, +…
Fresenius Medical Care AG & Co. KGaA ("the Company"), the world's largest provider of Dialysis Products and Services, to…
Summary Second Quarter 2008 (preliminary): Net revenue $ 2,665 million+ 11% Operating income (EBIT)$ 428 million+ 9%…
Based on preliminary figures, Group sales increased 9 % in constant currency and by 2 % at actual rates to € 5,710 milli…
. - Fresenius Confirms Positive Outlook for 2008 - 15th Consecutive Dividend Increase Approved Following the Compan…
Fresenius Medical Care AG & Co. KGaA (“the Company”), the world’s largest provider of Dialysis Products and Services, to…
Moody's has raised the corporate credit rating of Fresenius SE from Ba2 to Ba1. The ratings of the Senior Notes issued b…
Fresenius Medical Care AG & Co. KGaA ("the Company"), the world's largest provider of Dialysis Products and Services, to…
Fresenius Kabi, a business segment of health care group Fresenius, continues its growth strategy in intravenously admini…
Fresenius Medical Care AG & Co. KGaA ("The Company") today announced that the United States District Court for the North…